Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes

Insulin degludec (IDeg) once-daily was compared with insulin detemir (IDet) once- or twice-daily, with prandial insulin aspart in a treat-to-target, randomized controlled trial in children 1–17 yr with type 1 diabetes, for 26 wk (n = 350), followed by a 26-wk extension (n = 280). Participants were r...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Pediatr Diabetes
Päätekijät: Thalange, Nandu, Deeb, Larry, Iotova, Violeta, Kawamura, Tomoyuki, Klingensmith, Georgeanna, Philotheou, Areti, Silverstein, Janet, Tumini, Stefano, Ocampo Francisco, Ann-Marie, Kinduryte, Ona, Danne, Thomas
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons A/S 2015
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4413367/
https://ncbi.nlm.nih.gov/pubmed/25683037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pedi.12263
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia